Trademark Search in Canada

ADSIVITI

View On IC.GC.CA

REGISTERED

on 23 Sept 2020

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

Serial Number

1859620 filed on 26^th Sept 2017

Registration Number

TMA1081753 registered on 23^rd Sept 2020

Registration expiry Date

23^rd Sept 2030

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

K1P1J9

ADSIVITI

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for the treatment of alzheimer's disease, anxiety disorders, atopic dermatitis, autoimm Read More

Classification Information

Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease and dementia, neurological disorders namely mild cognitive impairment, and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification kind code

Mark Details

Serial Number

1859620

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 55 on 23^rd Sept 2020	Registered
Submitted for opposition 50 on 18^th Apr 2019	Allowed
Submitted for opposition 51 on 18^th Apr 2019	Allowance Notice Sent
Submitted for opposition 42 on 2^th Jan 2019	Advertised
Submitted for opposition 26 on 13^th Dec 2018	Approved
Submitted for opposition 22 on 26^th Oct 2018	Search Recorded
Submitted for opposition 27 on 26^th Oct 2018	Approval Notice Sent
Submitted for opposition 31 on 28^th Sept 2017	Formalized
Submitted for opposition 1 on 27^th Sept 2017	Created
Submitted for opposition 30 on 26^th Sept 2017	Filed